Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Dedicare - ABGSC Investor Days 8 mars 2022 - Krister Widstrom, CEO, Dedicare AB (publ)
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Dedicare - ABGSC Investor Days 8 mars 2022
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
David Hampstead on Samarkand Group's Strategy for Expanding European Brands in China | David Hampstead, CEO , Samarkand Global PLC.
00:10:00
A billion dollar company in her early twenties|Lucy Guo,Founder and General Partner,Scale
00:10:00
Weekly Market Update: Key Insights from EP Wealth Advisors | RYAN PARKER - CEO of EP Wealth Advisors
00:10:00
Marcin Kuśmierz on the Bright Future of Polish Businesses in the E-commerce Boom | Marcin Kuśmierz, President , Shoper SA.
00:10:00
First Mining Gold CEO Dan Wilton Presents Strategic Initiatives and Growth Prospects
00:00:00
Jean-Christophe Rain, PhD CEO and CSO, Hybrigenics
00:10:00
Navigating the Evolution: A Journey of Growth and Success in Real Estate Investment Trusts | Max El-Mann Arazi, President, Fibra Uno Administracion SA de CV.
00:10:00
Q3 2014 Market Update: Navigating Volatility and Economic Resilience
00:10:00
Atal's Strong Sales Outlook and Optimistic 2024 Projections Amidst Share Price Dip|President, Atal SA
00:10:00
Agnico Eagle: Sustainable Growth and Community Engagement
00:10:00
We back ambitious founders who actively seek to change|Zak Kukoff,Principal,General Catalyst
00:10:00
focusing on automation of the largest sectors of the Real Economy|Adeyemi Ajao,Managing Partner,Base10 Partners